|
|
 |
|
Viewing report
|
|
|
|
Global miRNA Market Outlook
RNCOS E-Services Private Limited, Dec 2011, Pages: 60
The emerging field of miRNA research has proven to be a promising contributor to modern medicine in recent times. miRNA has successfully provided the medical science community a new vision into the understanding of various types of diseases through clinical trials. Most of the research and clinical trials on miRNA are related to disease-specific profiling and functional analysis. Success of these trials would substantiate the role played by miRNAs in disease pathogenesis and thereby, facilitate the development of suitable therapeutics.
According to our latest report entitled, “Global miRNA Market Outlook”, the global research on miRNA is expected to grow at a stupendous rate in the coming years. Both, private and public sectors are stepping forward to provide huge financial support to fund these promising researches. Major pharmaceuticals and biotechnology companies are also showing impending interest in the research and research-related product segments. Such, high growth in the miRNA research is likely to boost the miRNA analysis of the products’ industry.
Currently, the research community is primarily focusing on the widespread chronic diseases, such as Cancer, Hepatitis, and Diabetes. Additionally, miRNA and its role in various diseases are being studied from a genetic point of view. Success in these areas would eventually fuel the movement into other important and rare diseases.
Our research also shows that the US and European countries including France, Germany, and Italy are the leading regions with a flourishing miRNA market. Asian countries, like India, China, Japan, and Singapore are also moving progressively into the field and are likely to become considerably large potential markets.
The report includes various techniques, like miRNA labeling, miRNA purification, etc., which are being used in the miRNA research. It provides a detailed description on the role of miRNAs in the pathogenesis of various diseases that is likely to provide a comprehensive overview of the miRNA market and its prospects.
|
|
|
|
